These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 35719962)
1. Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator. Li X; Yuan Y; Pal M; Jiang X Front Oncol; 2022; 12():929655. PubMed ID: 35719962 [TBL] [Abstract][Full Text] [Related]
2. Systematic Analysis and Validation of the Prognosis, Immunological Role and Biology Function of the Ferroptosis-Related lncRNA GSEC/miRNA-101-3p/CISD1 Axis in Lung Adenocarcinoma. Jiang X; Yuan Y; Tang L; Wang J; Zhang D; Duan L Front Mol Biosci; 2021; 8():793732. PubMed ID: 35320929 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA SNHG17 promotes lung adenocarcinoma progression by targeting the microRNA-193a-5p/NETO2 axis. Zhang Z; Yan Y; Zhang B; Ma Y; Chen C; Wang C Oncol Lett; 2021 Dec; 22(6):818. PubMed ID: 34671432 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis. Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106 [TBL] [Abstract][Full Text] [Related]
5. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804 [TBL] [Abstract][Full Text] [Related]
6. Identification of the pyroptosis‑related prognostic gene signature and the associated regulation axis in lung adenocarcinoma. Lin W; Chen Y; Wu B; Chen Y; Li Z Cell Death Discov; 2021 Jun; 7(1):161. PubMed ID: 34226539 [TBL] [Abstract][Full Text] [Related]
7. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression. Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X Front Oncol; 2022; 12():927988. PubMed ID: 35756681 [TBL] [Abstract][Full Text] [Related]
8. Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and Li X; Chen X; Yuan Y; Zhai R; Cho WC; Jiang X Front Oncol; 2022; 12():916947. PubMed ID: 35707363 [TBL] [Abstract][Full Text] [Related]
9. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma. Hu J; Wang T; Chen Q Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848 [TBL] [Abstract][Full Text] [Related]
10. Integrative Analysis and Experimental Validation Indicated That SNHG17 Is a Prognostic Marker in Prostate Cancer and a Modulator of the Tumor Microenvironment via a Competitive Endogenous RNA Regulatory Network. Li J; Yu H; Yao J; Jiang Z; Li Z; Cui X Oxid Med Cell Longev; 2022; 2022():1747604. PubMed ID: 35864871 [TBL] [Abstract][Full Text] [Related]
11. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of lncRNA-AC087588.2 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator. Jiang X; Chen X; Guo J; Zhou F; Pu J; Mutti L; Niu X Front Mol Biosci; 2022; 9():923584. PubMed ID: 35769906 [TBL] [Abstract][Full Text] [Related]
13. NCAPD2 is a novel marker for the poor prognosis of lung adenocarcinoma and is associated with immune infiltration and tumor mutational burden. Li Z; Zheng Y; Wu Z; Zhuo T; Zhu Y; Dai L; Wang Y; Chen M Medicine (Baltimore); 2023 Jan; 102(3):e32686. PubMed ID: 36701707 [TBL] [Abstract][Full Text] [Related]
14. SNHG17 upregulates WLS expression to accelerate lung adenocarcinoma progression by sponging miR-485-5p. Li W; Zheng Y; Mao B; Wang F; Zhong Y; Cheng D Biochem Biophys Res Commun; 2020 Dec; 533(4):1435-1441. PubMed ID: 33109341 [TBL] [Abstract][Full Text] [Related]
15. LINC00467 Is Upregulated by DNA Copy Number Amplification and Hypomethylation and Shows ceRNA Potential in Lung Adenocarcinoma. Wang W; Bo H; Liang Y; Li G Front Endocrinol (Lausanne); 2021; 12():802463. PubMed ID: 35095769 [TBL] [Abstract][Full Text] [Related]
16. Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung Adenocarcinoma. Chen X; Guo J; Zhou F; Ren W; Pu J; Mutti L; Niu X; Jiang X Front Oncol; 2022; 12():895708. PubMed ID: 35646670 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA SNHG17 promotes proliferation, migration and invasion of glioma cells by regulating the miR-23b-3p/ZHX1 axis. Ge BH; Li GC J Gene Med; 2020 Nov; 22(11):e3247. PubMed ID: 32602607 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive Pan-Cancer Analysis of the Prognostic and Immunological Roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C Axis. Jiang X; Yuan Y; Tang L; Wang J; Liu Q; Zou X; Duan L Front Cell Dev Biol; 2021; 9():765772. PubMed ID: 34858987 [TBL] [Abstract][Full Text] [Related]
19. High Expression of Chen Y; Zhou M; Gu X; Wang L; Wang C Dis Markers; 2022; 2022():8789515. PubMed ID: 35855850 [TBL] [Abstract][Full Text] [Related]
20. NcRNA-Mediated High Expression of Jiang X; Tang L; Yuan Y; Wang J; Zhang D; Qian K; Cho WC; Duan L Front Oncol; 2022; 12():846536. PubMed ID: 35311097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]